MedTrace Logo

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

NCT05910840 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-09-25

No results posted yet for this study

Summary

The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.

Conditions

  • Diabetes Mellitus
  • Diabetes Mellitus, Type 1
  • Glucose Metabolism Disorders (Including Diabetes Mellitus)
  • Metabolic Disease
  • Endocrine System Diseases
  • Autoimmune Diseases
  • Immune System Diseases

Interventions

OTHER

Support-t

Support-t plus usual diabetes care for 18 months

Sponsors & Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    collaborator OTHER

  • CSSS de Gatineau

    collaborator OTHER

  • Centre de recherche du CHU de Sherbrooke

    collaborator UNKNOWN

  • CHU de Quebec-Universite Laval

    collaborator OTHER

  • Anne-Sophie Brazeau

    lead OTHER

Principal Investigators

  • Anne-Sophie Brazeau, PhD · School of Human Nutrition - McGill University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-07
Primary Completion
2027-04-30
Completion
2027-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910840 on ClinicalTrials.gov